Submission on draft PBAC Guidelines

Mental Health Australia made a submission to the review of the Pharmaceutical Benefits Advisory Committee (PBAC) guidelines, calling on the guidelines to:

  • Embed consumer and carer participation in app processes that affect them
  • Ensure alignment with international best practice in consumer and carer participation in health technology assessment
  • Invest in capacity building for consumer and carer participation
  • Ensure careful consideration of the appropriate ‘comparator’ drug for mental health treatments
  • Ensure that PBAC consider the broader benefits from medications, for example, consideration of the ability for the consumer and carer to return to the workforce
AttachmentKindSize
PDF icon Submission on draft PBAC Guidelines letterPDF166.14 KB
Rate this article: 

Tags

consumers and carers, pharmaceuticals, pharmaceutical benefits scheme, consumers, carers, mental illness, medicines, submission